Duke University School of Medicine is withdrawing from the annual U.S. News & World Report rankings of medical schools, Dean Mary E. Klotman, MD, and Vice Dean for Education Edward Buckley, MD, said Friday.

Major donors Todd Brady, (MD’99, PhD’98) and Andrea Darling (MA’96, JD’99), a married couple of 26 years whose son, Alex, started as a freshman at Duke University in the fall of 2022, describe their path around Duke being connected by mentors, explained why they choose to give back, and shared what they hope to accomplish through their philanthropy.

Active participants in Law Enforcement Assisted Diversion were significantly less likely to be re-arrested and more likely to use behavioral health treatment, according to a study of four programs in North Carolina.

In this month’s EDI Spotlight, Redmond shares about her unique role as director of assessment and research in the Office of Equity, Diversity and Inclusion.

Four School of Medicine faculty members have been selected to receive 2023 Physician-Scientist “Strong Start” awards.

Monique Starks is the first investigator in the U.S. to be funded by the National Institutes of Health to explore development of a drone network that is capable of delivering AEDs to OHCA bystanders, and she’s flying high with some promising early observations.

Current medical standards for accessing stroke risk perform worse for Black Americans than they do for white Americans, potentially creating a self-perpetuating driver of health inequities.

How our bodies sense our environment and react to it is a big question, and how we answer it can have important implications for drug development.

Three individuals and two teams within the School of Medicine are among Duke’s 2022-23 Presidential Award winners. 

As chief operating officer at the Duke Human Vaccine Institute (DHVI), Thomas Denny is in the unique position of helping people fight flu and HIV, developing the next generation of COVID-19 vaccines, and all the while leading an annual $120 million enterprise.